Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.520
+0.200 (4.63%)
Mar 9, 2026, 2:29 PM EDT - Market open
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $255.22 million as of March 9, 2026. Its market cap has increased by 29.11% in one year.
Market Cap
255.22M
Enterprise Value
163.58M
1-Year Change
29.11%
Ranking
Category
Stock Price
$4.52
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $255.22M, an increase of 29.26%. That is a compound annual growth rate of 4.70%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 262.83M |
| Cybin | 262.69M |
| Minerva Neurosciences | 260.08M |
| Inhibikase Therapeutics | 257.15M |
| Surrozen | 252.09M |
| Ovid Therapeutics | 248.65M |
| Palisade Bio | 242.88M |
| Nuvectis Pharma | 237.37M |